Dopour Faliz M

No ORCID on file · 1 paper in corpus · active 2019
2019
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v18i1.6197

BackgroundOral progesterone is recommended as an alternative to gonadotropin-releasing hormone (GnRH) agonists and antagonists to prevent luteinizing hormone (LH) surge in assisted reproductive technology (ART) cycles. However, there are li…